Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
156.55
Change Change %
-1.15 -0.73%

Updated:19 Jul, 2019, 10:54 AM IST

BSE
156.65
Change Change %
0.15 0.10%

Updated:19 Jul, 2019, 11:03 AM IST

Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

156.20 158.50

52 Wk Range

125.00 205.00
Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

156.50158.60

52 Wk Range

125.00 204.00

Compare Price performance of vs. Peer Companies

From sector

Compare with Peers on Key Fundamentals and Financials

Color code for Price performance of and Peer companies

  • 5% and above
  • 2% to 5%
  • 0.5% to 2%
  • -0.5% to 0.5%
  • -2% to -0.5%
  • -5% to -2%
  • -5% and below
 

Bliss GVS Pharma's Key Fundamentals

Parameter Values
Market Cap (in ₹ Cr.) 1,614.77
Earning Per Share (EPS TTM) (₹) 7.21
Price To Earnings (P/E) Ratio 21.71
Book Value Per Share (₹) 52.49
Price To Books (P/B) Ratio 2.98
EBIT Margin (%) 31.44
PAT Margin (%) 19.11
ROCE (%) 15.60
PAT Growth (%) -3.58
Total Debt to Equity (D/E) Ratio 0.17

More from Key Fundamentals »

Bliss GVS Pharma's Financial Summary

Parameter MAR'18
(₹ Cr.)
MAR'17
(₹ Cr.)
YoY
%Change
Balance Sheet:
Share Capital 10.31 10.31 0.00%
Total Non-Current Liabilities 15.73 22.84 -31.13%
Total Current Liabilities 136.85 151.82 -9.86%
Total Liabilities 694.01 666.30 4.16%
Total Non-Current Assets 120.08 111.50 7.70%
Currents Investments 0.00 0.00 -100.00%
Cash and Bank 70.29 83.57 -15.88%
Total Current Assets Excluding Current Investments 573.93 554.80 3.45%
Total Assets 694.01 666.30 4.16%
Profit and Loss:
Gross Sales 298.29 350.27 -14.84%
Net Sales 297.89 348.02 -14.40%
PBIDT (Excl OI) 88.47 100.53 -12.00%
PAT 57.01 59.13 -3.58%

More from Financial Summary »

Bliss GVS Pharma's Shareholding Pattern

Bliss GVS Pharma held by Mutual Fund Schemes

Scheme Holding(%)
ICICI Prudential S&P BSE 500 ETF 0.01

More from Mutual Fund Holding »

..

Post your comments about Bliss GVS Pharma

Top